The Zn-dependent membrane-located protease YvjB has previously been shown to serve as a target receptor for LsbB, a class II leaderless lactococcal bacteriocin. Although yvjB is highly conserved in the genus Lactococcus, the bacteriocin appears to be active only against the subspecies L. lactis subsp. lactis. Comparative analysis of the YvjB proteins of a sensitive strain (YvjB MN ) and a resistant strain (YvjB MG ) showed that they differ from each other in 31 positions. In this study, we applied site-directed mutagenesis and performed directed binding studies to provide biochemical evidence that LsbB interacts with the third transmembrane helix of YvjB in susceptible cells. The site-directed mutagenesis of LsbB and YvjB proteins showed that certain amino acids and the length of LsbB are responsible for the bacteriocin activity, most probably through adequate interaction of these two proteins; the essential amino acids in LsbB responsible for the activity are tryptophan ( 
B
acteriocins are small, ribosomally synthesized, cationic, and hydrophobic peptides produced by various bacteria, and they are often found to be active against bacteria closely related to the producers. However, some also have broader inhibitory spectra, including pathogens and problematic bacteria. Producer organisms are immune to their own bacteriocin(s), a property that is mediated by specific immunity proteins (1) .
Bacteriocins from Gram-positive bacteria are generally classified into two main groups: the class I lantibiotics, containing posttranslationally modified peptides with ring-forming lanthionine or methyllanthionine residues, and class II, composed of nonmodified or minimally modified peptide bacteriocins (1) (2) (3) . Class II bacteriocins are further subdivided into pediocin-like bacteriocins (class IIa), two-peptide bacteriocins (class IIb), circular bacteriocins (class IIc), and nonpediocin one-peptide bacteriocins (class IId) (2) .
Bacteriocins have been much studied from a fundamental and scientific perspective and also for their potential applications as food preservatives, and in veterinary and human medicine as alternatives to antibiotics or as synergists (1, 4) .
Bacteriocins have a number of positive attributes that have made them especially attractive for various applications (5) . Some of them exhibit a broad spectrum of activity, inhibiting microorganisms belonging to different genera and species, including many bacterial pathogens that cause human, animal, or plant infections (6) . For clinical applications, bacteriocins have been presented as a viable alternative to antibiotics due to the high specificity of certain bacteriocins against clinical pathogens, including multidrug-resistant (MDR) strains (4) . Therefore, these substances have various potential applications in the food industry and medicine, either alone or in combination with other chemicals or methods (7) .
The multiplicity and diversity of bacteriocins and the resultant effects of their interactions with targeted bacteria on microbial ecology have been thoroughly studied and remain an area of investigation, attracting many researchers (8) .
The mechanisms involved in the inhibitory activity of bacteriocins produced by Gram-positive bacteria toward target cells have been shown to be diverse. Lipid II, along with related cell wall precursors, has been identified as both the receptor and the target for several class I bacteriocins from the lantibiotic subgroup (9) (10) (11) , as well as for the class II bacteriocin lactococcin 972 (12) . The mannose phosphotransferase system (man-PTS) has been found to be involved in the sensitivity to some bacteriocins, but it was not until 2007 that it was finally established that man-PTS serves as a receptor for the class IIa (i.e., pediocin-like) and some class IId bacteriocins (lactococcin A and lactococcin B) (13, 14) . In recent years, several other receptors have been identified through a genome sequencing approach. A maltose-ABC transporter was found to be required in target cells for sensitivity to garvicin ML, a circular bacteriocin (class IIc) (15) . By screening of a cosmid library and genome sequencing of resistant mutants, a Zn-dependent metallopeptidase was found to be the target for the LsbB (class IId) and related bacteriocins (16) . In addition, UppP has been found to be the bacteriocin receptor for lactococcin G and enterocin 1071 (both class IIb) (17) . Although all these bacteriocins differ greatly from each other in many aspects, including physicochemical properties, composition, target specificity, width of spectrum, and mode of action, they all share a feature, which is the fact that they all target components of the bacterial membrane.
LsbB is a 30-amino-acid (aa) leaderless class IId bacteriocin produced by Lactococcus lactis subsp. lactis BGMN1-5 (18) . It has a narrow inhibitory spectrum containing mostly lactococcal strains. The target receptor for LsbB is YvjB, a member of the highly conserved Zn-dependent membrane-located protease M50 protein family (16) . Some members of this protein family are known to be involved in gene regulation in response to stress in Escherichia coli and Enterococcus faecalis (19) (20) (21) (22) . However, the role of YvjB in Lactococcus is presently unknown. It seems that LsbB interacts with YvjB with its C-terminal part (23) . In this study, we further analyzed the residues of LsbB and its membrane receptor YvjB that are essential for their interaction.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The strains, their derivatives, and plasmids used in this study are listed in Table 1 . Lactococcal and enterococcal strains were grown in M17 medium (Merck GmbH, Darmstadt, Germany) supplemented with D-glucose (0.5% [wt/ vol]) (GM17) at 30°C. Escherichia coli DH5␣, TOP10, M15, and BL21(DE3) were used for cloning and propagation of constructs and were grown in Luria-Bertani (LB) broth aerobically at 37°C. To each medium, agar (1.5% [wt/vol]; Torlak, Belgrade, Serbia) was added for use as a solid medium. Transformants of lactococci and enterococci were selected on GM17 plates containing 10 g/ml erythromycin (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany) or 7.5 g/ml chloramphenicol (final concentration). E. coli transformants were selected on LB plates containing 300 g/ml erythromycin, 100 g/ml ampicillin, or 100 g/ml kanamycin, depending on the plasmids used. When necessary, 5-bromo-4-chloro-3-indolyl-D-galactoside (X-gal) (Fermentas, Vilnius, Lithuania) was added to LB or GM17 medium plates at a final concentration of 50 g/ml, for blue/white screening of colonies carrying vectors with clones.
Test for bacteriocin activity. For detection of bacteriocin activity of lactococci, recombinant strains, and mutants, an agar well diffusion assay was performed as described previously by Kojic et al. (24) . To test the level of LsbB production, zones of inhibition were compared by size and intensity with zones formed by synthetic LsbB (known concentrations) and two control strains, L. lactis BGMN1-596T and MG7284 carrying pAZILlsbB, in order to quantify production by different producers. DNA manipulations. Electrocompetent L. lactis subsp. cremoris MG7284 and Enterococcus faecalis BGZLS10-27 cells were prepared as described by Holo and Nes (25) . Transformations were done by electroporation using an Eppendorf electroporator (Eppendorf, Hamburg, Germany), except E. coli DH5␣, EC101, TOP10, M15, and BL21, which were transformed by heat shock. Appropriate agar plates with antibiotics were used for the selection of transformants.
Plasmid DNA from E. coli DH5␣, EC101, TOP10, M15, and BL21 was isolated using the QIAprep Spin miniprep kit (Qiagen GmBH, Hilden, Germany). Digestion with restriction enzymes was conducted according to the supplier's instructions (Fermentas). DNA fragments were purified from agarose gels using a QIAquick gel extraction kit, as described by the manufacturer (Qiagen).
DNA was ligated with T4 DNA ligase (Agilent Technologies, USA), according to the manufacturer's recommendations.
The sets of specific primers used in this study are listed in Table 2 . Kapa Taq DNA polymerase (Kapa Biosystems, Inc., Boston, MA, USA) was used to amplify DNA fragments by PCR using a GeneAmp PCR system 2700 thermal cycler (Applied Biosystems, Foster City, CA, USA). PCR products were purified with a QIAquick PCR purification kit (Qiagen), according to the protocol of the supplier, and sequenced by the Macrogen Sequencing Service (Macrogen, The Netherlands). The DNA Strider program was used for open reading frame (ORF) prediction. Commercial pGEM-T-Easy (Promega, Madison, WI, USA) or laboratory vector pBS-TA (26) was used for cloning of PCR products.
␤-Galactosidase activity assay. Membrane damage of lactococcal cells caused by LsbB was determined using a modified ␤-galactosidase assay described by O'Neill and coauthors (27) . The activity of ␤-galactosidase was determined from the logarithmic phase of MG7284, BGMN1-596, and BGMN1-596R2/23 (16) carrying pNZ8150lacZ1PlcnB (28) by assaying the degradation of ortho-nitrophenyl-␤-galactoside (ONPG) (Sigma-Aldrich Co., St. Louis, MO) at 30°C using a modified method described by Miller (29) . Cells from 1 ml of logarithmic-phase (optical density at 600 nm [OD 600 ], ϳ0.6) cultures were collected by centrifugation, resuspended in 500 l of PP buffer (0.5 M sucrose, 40 mM NH 4 -acetate, 10 mM Mg-acetate [pH 7]) containing 4 mg/ml lysozyme, and incubated 30 min at 37°C. Protoplasts were harvested by centrifugation (1,500 ϫ g) and resuspended in 200 l of TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8.0]). Suspensions were divided into two parts of 100 l and to each was added 500 l of Z buffer (60 mM Na 2 HPO 4 ·7H 2 O, 40 mM NaH 2 PO 4 ·H 2 O, 10 mM KCl, 1 mM MgSO 4 ·7H 2 O, 50 mM ␤-mercaptoethanol). To one mixture, 20 l of chloroform and 20 l of 0.1% SDS were added, and to a second mixture, LsbB (100 g/ml) was added. These mixtures were incubated for 10 min at room temperature (RT) before centrifuging at 16,000 ϫ g for 3 min to pellet undisrupted protoplasts. The supernatants were transferred to new tubes, and 200 l of ONPG (4 mg/ ml) was added. After the appearance of yellow color, the reactions were stopped by adding 250 l of 1 M Na 2 CO 3 , and A 420 values were measured for the supernatants. ␤-Galactosidase activity in Miller units was calculated as 1,000 ϫ A 420 /(t ϫ v ϫ OD 600 ), where t is time in minutes, v is the volume of culture used in the assay in milliliters, and OD 600 is the optical density of the culture at 600 nm. The efficiency of membrane damage caused by LsbB was calculated as the percentage of ␤-galactosidase activity obtained by treatment of cells with LsbB (100 g/ml) compared to those obtained by SDS and chloroform (activity obtained by treatment with SDS and chloroform was taken as 100%).
Site-directed mutagenesis. Desired mutations were introduced through the QuikChange site-directed mutagenesis protocol (Agilent Technologies, USA) with the oligonucleotide primers (and their reverse complements) listed in Table 2 . After PCR for site-directed mutagenesis, the methylated template strands were digested by 1 l (10 U) of DpnI restriction enzyme per reaction (at 37°C for 2 h) and purified by Thermo Scientific GeneJET PCR purification kit, as described by the manufacturer (Thermo Scientific, Lithuania). Subsequently, 4 l of the purified DNA was used to transform 40 l of E. coli TOP10 high-competency cells by heat shock treatment. The Thermo Scientific GeneJET plasmid miniprep kit was used, according to the manufacturer's recommendations (Thermo Scientific), to obtain and purify the plasmids from the selected colonies, after which sequencing (Macrogen Europe, The Netherlands) was done to confirm the introduction of the desired mutations. Preparation of bacterial cell membrane. The method for extracting cell membrane enzymes from selected lactococcal strains was applied according to Attri et al. (30), with modifications.
Cells from the bacterial log cultures (MG7284, BGMN1-596, and BGMN1-596/23) were harvested by centrifugation at 3,600 ϫ g for 10 min and the cell pellets washed in TEN buffer (50 mM Tris, 10 mM EDTA, 50 mM NaCl [pH 8.0]). Cell pellets (ϳ5 g) were suspended in 2 to 3 ml of PP buffer (see above) with addition of lysozyme (5 mg/ml) and stirred for 1 h at 37°C. Lysozyme-treated cells were harvested by centrifugation at 1,000 ϫ g at 4°C for 5 min, and pellets were resuspended in A buffer (50 mM sodium phosphate, 100 mM NaCl, 0.5% Triton X-100 supplemented with the protease inhibitor cocktail at a 1:200 [vol/vol] ratio [pH 8.0]). The cells were subjected to sonication for 1 min at a frequency of 8 kHz while being kept in an ice bath. The homogenate was centrifuged at 16,000 ϫ g for 30 min to obtain the supernatant. In the next step, the supernatant was centrifuged at 100,000 ϫ g for 18 h at 4°C to pellet the cell membranes. In order to obtain more pure membrane fractions, homogenates were centrifuged at 45,000 ϫ g for 5 h at 4°C. Supernatants representing cell cytoplasm and pellets representing the membrane fraction were stored in an ice bath (up to 7 days).
Production of polyclonal antibody. Synthetic LsbB (ChinaPeptides Co., Ltd., Shanghai, China) was used for production of anti-LsbB polyclonal antibody.
Two regions of YvjB protein (YvjBex1 from 80th to 185th amino acids and YvjBex2 from 225th to 300th amino acids) that do not contain intermembrane domains were expressed using the pQE 30 6ϫHis tag (Qiagen) expression system for the production of anti-YvjB polyclonal antibody. First, using total DNA BGMN1-596 and designed primers ex1 SacI/ HindIII for YvjBex1, and ex2 BamHI/HindIII for YvjBex2, corresponding fragments were amplified by PCR. The PCR products were purified and cloned first to pGEM-T-Easy vector, confirmed by sequencing, and recloned as SacI/HindIII or BamHI/HindIII in frame with 6ϫHis tag to pQE 30 expression vector. Fusion His-tagged proteins were expressed in E. coli M15 cells.
His tag affinity purification of YvjBex1 and YvjBex2 proteins was conducted under denaturing conditions. The refolding method using urea to disrupt noncovalent bonds and increase protein solubility was used to solubilize and make the His-tagged YvjBex1 and YvjBex2 more accessible to the nickel-nitrilotriacetic acid (Ni-NTA) resin. The recombinant proteins were purified according to the protocol recommended by The QIAexpressionist (Qiagen). The eluted proteins were dialyzed by ultrafiltration (centrifugal filter units; Amicon Ultra-15 centrifugal filter devices, 3K; Millipore). Polyclonal antibodies were produced by immunization of mice with the synthetic or purified fusion proteins in the animal house of the International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Construction of GST-LsbB-tag protein and GST pulldown assay. Specific sets of primers [LsbB-tag(GST)-F and LsbX-Sal-R; Table 2 ] were designed for amplification of selected a part of the lsbB gene from pMN5 plasmid DNA. The PCR product was purified and cloned to pGEM-TEasy vector and confirmed by sequencing. The lsbB gene was transferred from pGEM-T-Easy as a BamHI/SalI fragment into the expression vector pGEX-6P-3 to obtain glutathione S-transferase (GST)-LsbB fusion protein. After transforming the expression vector into competent E. coli BL21 cells, BL21/p-GEX-6P-3/LsbB and BL21/p-GEX-6P-3 (control strain with empty vector) were grown in 50 ml of LB broth (containing 100 g/ml ampicillin) to an OD 600 (A 600 ) of 0.6, with vigorous agitation at 37°C. Before the next step, 1 ml of the cultures was collected (noninduced samples). Fusion protein expression was induced by 0.1 mM isopropyl-␤-Dthiogalactoside (IPTG) (Sigma-Aldrich) by incubating the cultures for an additional for 2 h at 28°C. One milliliter of the cultures was collected (induced samples) and analyzed. Noninduced and induced samples for both strain BL21/p-GEX-6P-3/LsbB and BL21/p-GEX-6P-3 were boiled for 2 min and checked by protein gel electrophoresis (12.5% gel) prior to Coomassie blue staining. The rest of the BL21/p-GEX-6P-3/LsbB and BL21/p-GEX-6P-3 (control strain) bacterial cultures were harvested by centrifugation at 4,500 ϫ g for 10 min, and the cell pellets were suspended in 3 ml of lysis buffer containing 0.5% Triton X-100, 0.2% SDS, 0.5% NP-40, and 0.1% Tween 20. The cells were lysed in the ice for 30 min with gentle agitation. The lysates were subjected to sonication for 1 min (6 times 10 s) at a frequency of 10 kHz while being kept in an ice bath. The homogenate was centrifuged at 10,000 ϫ g for 30 min at 4°C to obtain the supernatant. In order to bind the engineered tagged protein to the matrix, supernatants of BL21/p-GEX-6P-3/LsbB and BL21/p-GEX-6P-3 were incubated with glutathione Sepharose 4 Fast Flow (GE Healthcare, Germany) for 2 h at 4°C with continuous mixing.
Beads of glutathione Sepharose (200 l) with bound proteins were centrifuged briefly and washed with the same lysis buffer at 4°C. The quantity of GST-LsbB fusion protein and GST protein (20 l per each) was tested by SDS-PAGE and Western blot analysis using anti-LsbB antibody. Equal amounts of beads with bound GST-LsbB and GST (50 l each) proteins were homogeneously mixed with the membrane fractions of strains MG7284, BGMN1-596, and BGMN1-596R2/23 (50 l each) and made up to a volume of 600 l with supplement buffer (50 mM Tris, 120 mM NaCl [pH 6.8]). The mixture was incubated overnight at 4°C with gentle agitation, washed five times for 30 min each in phosphatebuffered saline (PBS) buffer (10 mM Na 2 HPO 4 , 1 mM KH 2 PO 4 , 140 mM NaCl, 3 mM KCl [pH 7.1]), and protein complexes were pulled down.
Western blotting. Protein(s) associated with the GST-LsbB fusion protein and GST protein was analyzed by SDS-PAGE and Western blot assays using anti-YvjB and anti-LsbB antibodies (independently). Samples were loaded into a 12.5% polyacrylamide gel, subjected to electrophoresis, and transferred to a polyvinylidene difluoride (PVDF) membrane (Merck Millipore, Darmstadt, Germany) for 1 h at appropriate voltage (constant voltage). Membranes were incubated with 10% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) overnight at 4°C in order to block nonspecific binding. Following blocking, the membranes were incubated for 1 h at RT with gentle agitation in appropriate dilutions of primary antibodies, as follows: mouse polyclonal antibody anti-YvjB, 1:3,000 dilution, and mouse polyclonal antibody antiLsbB, 1:5,000 dilution (independently). Primary antibodies were diluted in 5% skim milk in TBST. After washing three times in TBST for 15 min, membranes were incubated for 1 h with horseradish peroxidase-labeled anti-mouse IgG (A9044 anti-mouse; Sigma) at a 1:10,000 dilution in 5% skim milk in TBST. The blots were washed three times in TBST for 15 min. Bands of target proteins were detected using the CN/DAB substrate kit (Thermo Scientific), according to the manufacturer's instructions.
Immunocytochemistry. After plating on coverslips, bacterial cells were fixed in 4% paraformaldehyde (PFA) for 20 min at RT. Cells were blocked in 5% bovine serum albumin (BSA) in PBS for 1 h at RT. Primary antibodies were diluted in PBS containing 1% BSA and incubated overnight at 4°C with mouse polyclonal anti-LsbB (this study, diluted 1:50). Coverslips were washed three times for 10 min in PBS and incubated with biotinylated goat anti-mouse IgG (Vector, Burlingame, CA, USA) for 1 h at RT in 1% BSA, followed by Cy3-streptavidin (diluted 1:5,000; Jackson ImmunoResearch, West Grove, PA, USA) diluted in PBS for 1 h at RT. Bacterial DNA was stained with 0.1 mg/ml 4=,6-diamino-2-phenylindole (DAPI; Sigma-Aldrich). Samples were visualized under an Olympus BX51 fluorescence microscope with appropriate filters and analyzed using the CytoVision 3.1 software (Applied Imaging Corporation, USA).
RESULTS

LsbB causes membrane damage of sensitive cells.
To determine whether LsbB causes membrane damage, different lactococcal strains with different levels of sensitivity to LsbB were exposed to synthetic LsbB. These were the resistant strain MG7284, the sensitive strain BGMN1-596, and the semisensitive mutant BGMN1-596R2/23 (see Table 1 ). The strains were transformed with pNZ8150lacZ1PlcnB encoding ␤-galactosidase, which was used as a reporter system for the detection of membrane damage. The results showed that the level of ␤-galactosidase activity (and thus membrane damage) is directly correlated with the level of sensitivity to LsbB (see Fig. S1 in the supplemental material), i.e., more ␤-galactosidase activity was found in sensitive cells than in lesssensitive cells. The results provide evidence that LsbB kills target cells by membrane damage.
Identification of essential amino acid residues in LsbB bacteriocin involved in antimicrobial activity. We have previously demonstrated that the last C-terminal 8 amino acids of the LsbB bacteriocin are involved in the interaction with the receptor protein YvjB (23) . The residue Trp 25 plays a particularly important role, as the substitution Trp 25 to Ala caused a total loss of antimicrobial activity. To further study the importance of Trp 25 and other amino acids in receptor binding, additional amino acid substitutions were made in LsbB (Fig. 1) . It was found that the substitution of Trp 25 with Phe, an amino acid belonging to the same aromatic group, caused a small reduction in bacteriocin activity, indicating the involvement of specific groups on amino acid 25 in specific interactions with YvjB (Fig. 1B) . Previous work indicates that the last residue, Ala 30 , is important for bacteriocin activity. As expected, the deletion of the terminal Ala 30 , the addition of another alanine at the end (Ala 31 ), or the substitution of Ala 30 with Pro caused a total loss of antimicrobial activity of LsbB, whereas substitutions of Ala 30 with other residues, such as Gly and Val, had no apparent impact on the bacteriocin activity, while substitution with Ser enhanced bacteriocin activity (Fig. 1A) . In our previous To assess the importance of the N-terminal half, we created a double mutant; Lys 2 and Thr 3 were changed to Asn 2 and Ser 3 , respectively. The activity of the modified peptide did not change drastically (Fig. 1D) , indicating that the N-terminal part of LsbB seems to be less sensitive to changes/modifications.
One of the peptides (LcnG-␣) of the two-peptide bacteriocin lactococcin G (like LsbB) contains a series of cationic residues (Arg 35 Lys 36 Lys 37 Lys 38 His 39 ) at the C-terminal part, and it has been proposed that this feature functions as a means to force the peptide to the target cell membrane by electrostatic interaction (31) . LsbB contains a similar string of basic residues in its C-terminal half ( adverse effect on bacteriocin activity; in fact, it even slightly enhanced the activity (Fig. 1C) .
Based on all these amino acid substitutions, deletions, and additions, it is possible to conclude that the C-terminal part of the LsbB bacteriocin is most important for bacteriocin activity, likely through interaction with the receptor protein YvjB.
Mapping of the region on YvjB involved in LsbB interaction. It has previously been established that among lactococci, there exist both sensitive and resistant strains to LsbB, such as the resistant strain MG7284 and the sensitive strain BGMN1-596, both of lactococcal genotype. The LsbB-resistant strain MG7284 possesses a homolog of YvjB (YvjB MG ) that differs in 31 residues from the YvjB of the sensitive strain BGMN1-596 (YvjB MN ). These differences appear to be randomly distributed over the entire protein length (Fig. 2) . To search for the regions in YvjB MN and YvjB MG that cause their different sensitivity to LsbB, hybrid proteins containing portions of both proteins were constructed (see Fig. S2 in the supplemental material). A hybrid protein containing the Cterminal half of YvjB MN and the N-terminal half of YvjB MG (YvjB 1/2MG-1/2MN ) was able to confer sensitivity to LsbB when expressed in strain MG7284 (naturally resistant to LsbB), indicating that the C-terminal half of YvjB MN is involved in target specificity. Further, a hybrid protein (YvjB 3/4MG-1/4MN ) with an even smaller part of YvjB MN at the C terminus was still capable of conferring sensitivity to LsbB. Different hybrid combinations, as depicted in Fig. S2 , further confirmed that the last section of the C terminus of YvjB is most likely involved in direct interaction with LsbB and consequently in sensitivity to the bacteriocin.
Given that the potential LsbB-binding domain is located at the C-terminal end of YvjB, we are interested in finding the mem- brane topology of this part. Using Phobius (http://phobius.binf .ku.dk/index.html) or TMHMM server version 2.0 for prediction of transmembrane (TM) helices in proteins (http://www.cbs.dtu .dk/services/TMHMM/), YvjB was predicted to possess four transmembrane (TM) domains: TMI from amino acids (aa) 5 to 27, TMII from aa 188 to 210, TMIII from aa 354 to 376, and TMIV from aa 401 to 423 ( Fig. 2; (Fig. 2) . Some of these differences are likely responsible for the observed difference between YvjB MG and YvjB MN in terms of sensitivity to LsbB. Four of YvjB MG 's six amino acids belong to different physicochemical groups from the ones in YvjB MN . These were therefore mutated separately and in combination, in both the YvjB MG and YvjB 3/4MN-1/4MG proteins (in constructs pAZILyvjB MG and pAZILyvjB 3/4MN-1/4MG , respectively), into the residues present in YvjB MN in order to determine which amino acid(s) is directly responsible for the sensitivity to LsbB. In the first round of mutagenesis (single amino acid changes), it is worth noting that Tyr 356 was able to transform carrier cells from a resistant to a sensitive phenotype (Fig. 3) . This sensitivity occurred, in fact, in both tested YvjB proteins (MG7284/YvjB MG and MG7284/ YvjB 3/4MN-1/4MG ), although the zone of inhibition by BGMN1-596T as an LsbB producer was smaller than for YvjB MN . This smaller zone of inhibition indicated a possible additional effect of other amino acids in the interaction with LsbB. In the second round of site-directed mutagenesis (when different combinations of two, three, or four amino acids were changed), some interesting results were obtained, as depicted in Fig. 3 . First, only the changes in combination with Gln 356 Tyr could cause sensitivity of the carriers. However, the zones of inhibition of these mutants were different in size and transparency; for example, adding the change Leu 351 Phe to Gln 356 Tyr slightly increased the clear inhibition zone (Fig. 3) . Additionally, the change Gln 356 Tyr plus Thr 353 Ala drastically increased the zone of inhibition, which was even larger than with YvjB MN : however, it contained a high number of revertantlike resistant colonies ( Fig. 3 ; see also Fig. S4 in the supplemental material). Triple and quadruple amino acid changes to YvjB MG and YvjB 3/4MN-1/4MG showed that additional changes reduced the number of revertant-like resistant bacteria in the inhibition zone and restored the size of the zone to the size obtained with YvjB MN . In summary, it was concluded that the amino acid in the YvjB receptor most responsible for the interaction with LsbB and the sensitivity of cells to LsbB is Tyr 356 , whereas the other amino acids are also important but to a lesser extent than Tyr 356 . It is worth noting that the residue Tyr 356 is located at the beginning of the predicted third transmembrane helix (from residue 355 to residue 376), with the C-terminal end pointing toward the cytoplasm. More important, Tyr 356 is closely flanked by three residues that differentiate YvjB MG from YvjB MN in this region, suggesting that these residues together probably form a site to which LsbB binds to kill target cells.
LsbB interacts directly with YvjB. It was of interest to determine if the LsbB bacteriocin interacts directly with the YvjB receptor.
In a GST pulldown assay, LsbB coupled to GST (it was decided to fuse the GST tag at the N terminus of LsbB, as our previous studies determined that the C terminus was important for the interaction with the target receptor [23] ) was able to bind YvjB MN protein from membrane fractions and to retain it during stringent washing (Fig. 4) . Similar experiments determined that YvjB MG and YvjB MNR2/23 proteins were able to bind LsbB but much less efficiently than YvjB MN (Fig. 4B, lanes 2, 9, and 5, respectively) . In the control reaction with GST alone, no unspecific binding was detected (Fig. 4B, lanes 3, 6, and 8, respectively) .
The GST pulldown assay is an in vitro assay. Thus, to determine the interaction in vivo, an analysis with fluorescent antibodies against YvjB and LsbB proteins was performed in live cells. The immunocytochemistry assay was performed with transformants of E. faecalis BGZLS10-27 harboring the pAZIL vector carrying different yvjB genes (yvjB MN and yvjB MG ). We used the enterococcal strain as a host, because there was no lactococcal strain without endogenous YvjB protein to serve as a negative control (the neg- ative control was strain BGZLS10-27 transformed with empty pAZIL vector). In addition, this particular enterococcal strain was used because it was resistant to LsbB and nonreactive with the antibodies used (data not shown). Before beginning this assay, the sensitivity of BGZLS10-27 transformants carrying different constructs was confirmed by an antimicrobial assay (see Fig. S5 in the supplemental material). The in vivo immunocytochemistry assay showed that LsbB interacts specifically with the cells expressing YvjB MN (Fig. 5) . Full matching of the color that locates the presence of transformed cells (DAPI) and fluorescent antibody that locates LsbB bacteriocin (LsbB) is obtained only when transformants BGZLS10-27/pAZIL-YvjB MN (merge) were used. In experiments that used the transformants carrying empty plasmid BGZLS10-27/pAZIL (control) or cloned YvjB gene from the strain MG7284 (BGZLS10-27/pAZIL-YvjB MG ), colocalization of these two signals was not obtained.
DISCUSSION
In recent years, two important needs have emerged: the increasing consumer demand for natural food preservatives, such as bacteriocins produced by lactic acid bacteria, and the demand for new antimicrobial compounds in response to the continuing emergence of antibiotic-resistant bacteria, in the face of declining numbers of new antibiotics (32) (33) (34) . Consequently, the research and application of bacteriocins are ever-more-attractive propositions. Until now, it has been shown that the antimicrobial activity of bacteriocins is directly related to the presence of specific receptor proteins in the membranes of target bacteria. Thus, information on the receptors to which bacteriocins bind is potentially of great importance (4) .
In our previous studies, we identified the Zn-dependent metallopeptidase YvjB as the receptor for the bacteriocin LsbB (16) and further established that the C-terminal part of LsbB is involved in the interaction with the receptor protein YvjB (23) . In this work, we combined site-directed mutagenesis with the construction of hybrid protein molecules to define the residues of LsbB and YvjB involved in the interactions that eventually lead to the killing of target cells. We demonstrated that the essential amino acids are Trp 25 Such a site-directed mutagenesis approach has been used for amino acid substitution in different bacteriocins of lactic acid bacteria to analyze function or to improve antimicrobial activity (35) (36) (37) (38) (39) (40) . The results obtained by site-directed mutagenesis of the LsbB bacteriocin are consistent with data obtained by other laboratories, where most amino acid substitutions cause a reduction in or complete loss of activity. It is interesting, however, that some substitutions, such as alanine to serine (Ala 30 Ser), enhanced bacteriocin activity, most likely due to better interaction and positioning in the YvjB receptor. In addition, we suggest that not only residues Trp 25 and Ala 30 , but also the distance between them, play an essential role in the antimicrobial activity of LsbB.
The construction of hybrid molecules and site-directed mutagenesis with structure-function assays enabled us to define essential domains responsible for the interaction of the target receptor YvjB with LsbB. It is interesting that all key amino acids involved in the interaction with LsbB are located in the beginning of the penultimate transmembrane domain of YvjB ( Fig. 2; S3 ). In contrast, the beginning of the second transmembrane domain is located closer to the cytoplasmic side, indicating that both sides of the membrane are involved in the interaction of YvjB with LsbB, causing membrane damage of cells. It could be postulated that the third transmembrane domain is involved in the first interaction with LsbB, but the second transmembrane domain is also important for complex formation and membrane damage of sensitive cells. Mutants with an amino acid substitution in the second transmembrane domain, such as Gly 188 Ser, are semiresistant, meaning that they can interact with LsbB on the surface but require higher concentrations of LsbB for complex formation and membrane damage of the cells. Given that LsbB in vitro was able to interact with all three YvjB proteins (from resistant strain MG7284, semiresistant mutant BGMN1-596R2/23, and sensitive strain BGMN1-596) but not in vivo indicates the involvement of other factors present in cell wall in the control of the interaction. Any changes to the essential amino acids in the bacteriocin receptor protein cause partial or complete resistance to certain bacteriocins. For this reason, it is important to identify specific receptors for bacteriocins and the domains involved in the interaction. The identification of new bacteriocin receptors present in potential target bacteria and understanding of their mechanisms of action are of great importance for the design of target-specific engineered antimicrobials.
